About NOVOMEDIX LLC
Novomedix is a biotechnology company developing novel small molecule multi-pathway modulators for the treatment of cancer, fibrosis, and inflammatory diseases. The company has decades of drug development experience and a broad pipeline stemming from its proprietary technology platform.
Development of novel small molecule multi-pathway modulatorsDrug discovery and developmentProprietary technology platform for oral small molecule IL-11 inhibitorsPipeline programs targeting cancer, fibrosis, and inflammatory diseases
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| SBIR PHASE II - ENHANCED OVERALL SURVIVAL IN HIGH-RISK PEDIATRIC SOLID TUMORS USING A NOVEL ORAL SMALL MOLECUL | Department of Health and Human Services | $3.0M | |
| SBIR CONCEPT AWARD TO NOVOMEDIX- NOVEL SMALL MOLECULES FOR THE TREATMENT OF RHABDOMYOSARCOMA | Department of Health and Human Services | $355K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to NOVOMEDIX LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.